103 related articles for article (PubMed ID: 4651200)
1. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
Engelmann C; Schulz K; Nowotny P; Konrad H
Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200
[No Abstract] [Full Text] [Related]
2. [Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
Demidova AV; Sysoeva NA
Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):23-7. PubMed ID: 1071792
[No Abstract] [Full Text] [Related]
3. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
Maurice PA
Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
[No Abstract] [Full Text] [Related]
4. [Clinical aspects of osteomyelofibrosis and osteomyelosclerosis].
Engelmann C; Schulz K; Nowotny P; Konrad H
Z Gesamte Inn Med; 1975 May; 30(9):326-30. PubMed ID: 1224743
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of osteomyelosclerosis and osteomyelofibrosis].
Treske U
Dtsch Med Wochenschr; 1970 Aug; 95(33):1691-2. PubMed ID: 5447788
[No Abstract] [Full Text] [Related]
6. Treatment of myeloproliferative diseases.
Sellei C
Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
[No Abstract] [Full Text] [Related]
7. Treatment of AGL.
Lee SL; Rosner F
Arch Intern Med; 1969 Feb; 123(2):205-6. PubMed ID: 5249563
[No Abstract] [Full Text] [Related]
8. Myelofibrosis: response to busulfan after hydroxyurea failure.
Naqvi T; Baumann MA
Int J Clin Pract; 2002 May; 56(4):312-3. PubMed ID: 12074218
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
Gerhartz H
Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
[No Abstract] [Full Text] [Related]
10. [Cytostatics in the treatment of nephritides].
Tarejew EM; Muchin NA; Poljanzewa LR; Tarejewa IE
Dtsch Gesundheitsw; 1970 Oct; 25(44):2068-71. PubMed ID: 5491290
[No Abstract] [Full Text] [Related]
11. Results in the treatment of chronic myeloid leukaemia.
Nasr AL; Aboul-Enein M; Tawfik HN
Haematologica; 1972 Apr; 57(11):794-802. PubMed ID: 4200314
[No Abstract] [Full Text] [Related]
12. [The therapy of hemoblastosis and malignant lymphoma. I. Leukosis, polycythemia vera and osteomyelosclerosis].
Löffler H; Schultis K
Med Welt; 1968 Jan; 1():96-100. PubMed ID: 5704123
[No Abstract] [Full Text] [Related]
13. [Treatment procedures in myelofibrosis].
Klimova NF
Probl Gematol Pereliv Krovi; 1978; 23(11):31-5. PubMed ID: 714890
[No Abstract] [Full Text] [Related]
14. [Progress in the therapy of leukoses].
Stacher A
Wien Med Wochenschr; 1970 Jun; 120(24):441-3. PubMed ID: 5286401
[No Abstract] [Full Text] [Related]
15. [Attempts of the use of cytostatic agents in some forms of glomerulonephritis in children].
Nowak S; Bodalski J; Margolis A; Michalak A
Pediatr Pol; 1969 May; 44(5):549-60. PubMed ID: 5791319
[No Abstract] [Full Text] [Related]
16. Reversal of osteomyelosclerosis-associated systemic lupus nephritis.
Vora BJ; Byers RJ; Lucas GS; Gokal R
Nephrol Dial Transplant; 1998 Jun; 13(6):1559-61. PubMed ID: 9641195
[No Abstract] [Full Text] [Related]
17. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
Urasiński I; Mysik M
Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
[No Abstract] [Full Text] [Related]
18. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
Rukavitsyn OA; Pop VP; Seriakov AP
Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
[TBL] [Abstract][Full Text] [Related]
19. [Mycological studies in osteomyelosclerosis].
Sobótka S; Knap J; Sobótka W
Pol Tyg Lek; 1970 Nov; 25(47):1804-5. PubMed ID: 5484518
[No Abstract] [Full Text] [Related]
20. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
Böhnel J; Stacher A
Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
